Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesOrthopedics/MusculoskeletalOrthoNet investigational technologies Coverage | O…
    Ask Trek AI about this page
    CurrentorthonetPolicy 350

    Experimental and Investigational Technologies

    Customize your policy alerts

    Sign up for orthonet Policy 350 alerts

    Get alerted when Policy 350 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs how OrthoNet/Optum determines whether a healthcare technology (service, procedure, device, supply, or drug) is considered experimental or investigational and therefore denied; applies to utilization review across in- and out-of-network providers when no other policy exists.

    Policy Summary
    Payerorthonet
    PolicyExperimental and Investigational Technologies
    Policy CodePolicy 350
    Change TypeNo material changes
    Effective DateApr 30, 2026
    Last ReviewApr 30, 2026
    Next Review DateApr 30, 2026
    Key ActionApply this policy when making utilization review determinations for in- and out-of-network programs if no other policy or coverage statement applies.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    all providersScope coverage
    04/30/2026Last approved
    since 2001Review history span
    explicit criteriaDecision framework

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria for Investigational / Experimental Technologies

    Investigational / Experimental Determination

    Technologies are classified as investigational/experimental when any of the following conditions are met:

    Investigational / Experimental criteria: The technology meets any of the following: not of proven benefit for the specific diagnosis or treatment; not generally recognized by the medical community as effective or appropriate for the diagnosis or treatment of a particular condition; uncertainty about the risks associated with the proposed use of the technology, including the risk of not receiving established and effective intervention; generally provided or performed in special settings for research purposes or under a controlled environment or clinical protocol.

    Determination is based on transparent, evidence‑informed processes including methods to identify evidence, critical appraisal, and contextual judgment; findings are translated consistent with member benefit documents.

    This policy does not apply to healthcare technologies employed within clinical trials.

    A technology (service, procedure, device, supply, or drug) that is deemed investigational or experimental will be denied based upon the applicable exclusions recorded in the member's benefit coverage document or medical policy; or as not medically necessary in accordance with the criteria established by Optum.

    Provider Actions, Authorization, and Denial Basis

    Prior Authorization

    Prior authorization applicability

    Applies to Utilization Review determinations for all in- and out-of-network programs and all provider types when no other policy, criteria, or coverage statement is available; prior authorization requirements follow applicable Utilization Review processes.

    • Scope covers all in- and out-of-network programs and all provider types where Utilization Review determinations are rendered.
    • This policy is applicable only when there is no other policy, criteria, or coverage statement available.
    Step Therapy

    Step therapy not addressed

    Step therapy sequencing is not addressed by this policy; the document focuses on classification of technologies as investigational or experimental rather than specifying step therapy requirements.

    Documentation Required

    Evidence-informed documentation required

    Determinations that a technology is investigational or experimental are based on transparent, evidence-informed processes that describe methods to identify evidence, include critical appraisal of research, and incorporate considered judgments and contextual factors; findings are translated into terminology consistent with member benefit documents.

    • Document methods used to identify and select evidence and the critical appraisal approach.
    • Record considered judgments and contextual factors that informed the determination.
    • Ensure translation of findings aligns with the member's benefit coverage language.
    Denial Risk

    Denial basis for investigational technologies

    Technologies deemed investigational or experimental will be denied either based on applicable exclusions in the member's benefit coverage document or as not medically necessary in accordance with Optum/OrthoNet criteria.

    • Cite the specific member benefit exclusion when applicable.
    • When denying as not medically necessary, reference the Optum criteria used to assess investigational status.

    Background

    Experimental or investigational technologies are those that are not of proven benefit for a particular diagnosis or treatment, are not generally recognized by the healthcare community as effective or appropriate, and have uncertainty about associated risks; they are generally provided in research or controlled environments. Determinations consider regulatory status, the strength and quality of peer-reviewed evidence, whether the technology improves net health outcomes, comparative benefit and safety versus established alternatives, and whether expected improvements are achievable in routine clinical practice. Evidence review follows transparent, evidence-informed methods (including identification and critical appraisal of studies) and aligns decisions with applicable member benefit documents.

    Definitions

    Experimental or investigational
    DefinitionNot of proven benefit for the particular diagnosis or treatment of a particular condition.
    Recognition in literatureNot generally recognized by the healthcare community as effective or appropriate for the particular diagnosis or treatment, as reflected in published peer-reviewed clinical/scientific literature.
    Uncertain riskThere is uncertainty about the risks associated with the proposed use, including the risk of not receiving established and effective intervention.
    Usual settingGenerally provided or performed in special settings for research purposes or under a controlled environment or clinical protocol.
    Coverage consequenceTechnologies meeting these criteria are classified as investigational/experimental and are denied as not medically necessary per the policy and applicable benefit exclusions.
    Peer-review
    PurposeSubjects research studies to scrutiny by experts in the same field (peers) to ensure scientific quality.
    RoleUsed as a standard for recognizing credible, vetted clinical/scientific evidence in determinations of whether a technology is established or investigational.
    ProcessInvolves evaluation of study methods and findings by independent experts prior to publication or acceptance in the scientific community.
    Policy Summary
    Payerorthonet
    PolicyExperimental and Investigational Technologies
    Policy CodePolicy 350
    Change TypeNo material changes
    Effective DateApr 30, 2026
    Last ReviewApr 30, 2026
    Next Review DateApr 30, 2026
    Key ActionApply this policy when making utilization review determinations for in- and out-of-network programs if no other policy or coverage statement applies.
    SourceLink
    On This Page
    Coverage Criteria for Investigational / Experimental TechnologiesProvider Actions, Authorization, and Denial BasisBackgroundDefinitions